ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,737 | -9.2% | 100,839 | +2.8% | 0.02% | -10.0% |
| Q2 2023 | $3,015 | +1.3% | 98,077 | +18.8% | 0.02% | 0.0% |
| Q1 2023 | $2,975 | +95.6% | 82,570 | +114.5% | 0.02% | +81.8% |
| Q4 2022 | $1,521 | -99.9% | 38,487 | -46.4% | 0.01% | -47.6% |
| Q3 2022 | $2,885,000 | -7.4% | 71,796 | -3.1% | 0.02% | 0.0% |
| Q2 2022 | $3,116,000 | -33.8% | 74,110 | -38.6% | 0.02% | -12.5% |
| Q1 2022 | $4,706,000 | +78.3% | 120,798 | +82.4% | 0.02% | +100.0% |
| Q4 2021 | $2,639,000 | +159.5% | 66,212 | +135.2% | 0.01% | +140.0% |
| Q3 2021 | $1,017,000 | +8.0% | 28,147 | +22.4% | 0.01% | 0.0% |
| Q2 2021 | $942,000 | -41.5% | 22,988 | -37.8% | 0.01% | -44.4% |
| Q1 2021 | $1,611,000 | +209.8% | 36,929 | +255.3% | 0.01% | +200.0% |
| Q4 2020 | $520,000 | +114.0% | 10,394 | +107.9% | 0.00% | +50.0% |
| Q2 2020 | $243,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |